West Pharmaceutical Services, Inc. Stock Börse Stuttgart
Stocks
WPS
US9553061055
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 317.70 EUR | +1.15% |
|
+0.45% | +35.79% |
| Market Cap | 25.32B 22.27B 20.69B 19.03B 35.68B 2,452B 36.32B 247B 96.5B 1,196B 95.06B 93B 4,149B | P/E 2026 * |
42.3x | P/E 2027 * | 37.3x |
|---|---|---|---|---|---|
| Enterprise Value | 25.21B 22.18B 20.6B 18.95B 35.53B 2,442B 36.17B 246B 96.09B 1,191B 94.66B 92.61B 4,132B | EV / Sales 2026 * |
7.55x | EV / Sales 2027 * | 6.95x |
| Free-Float |
93.54% | Yield 2026 * |
0.24% | Yield 2027 * | 0.27% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 week | +0.58% | ||
| Current month | +0.45% | ||
| 1 month | +9.33% | ||
| 3 months | +33.77% | ||
| 6 months | +49.15% | ||
| Current year | +35.45% |
| 1 week | 302.6 |  | 341.3 |
| 1 month | 284.3 | | 341.3 |
| 3 years | 167.95 | | 386.2 |
| 5 years | 167.95 | | 411.2 |
| 10 years | 63.03 | | 411.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 2015-04-23 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.15% | +0.45% | +70.57% | -6.91% | 25.32B | |
| +0.19% | +1.84% | -20.01% | -12.19% | 175B | |
| +0.23% | -1.70% | -10.73% | -7.46% | 105B | |
| +0.91% | -1.53% | +3.36% | +58.41% | 58.48B | |
| -0.82% | -1.93% | +38.23% | +58.17% | 51.36B | |
| -0.04% | -4.27% | -16.15% | -45.32% | 42.2B | |
| +0.94% | -8.73% | - | - | 31.44B | |
| -1.07% | -9.40% | -18.26% | -44.68% | 27.56B | |
| -0.01% | -4.73% | -6.56% | -9.26% | 20.52B | |
| -1.86% | -0.99% | -8.50% | -1.37% | 19.89B | |
| Average | -0.18% | +0.72% | +3.55% | -1.18% | 59.05B | |
| Weighted average by Cap. | +0.04% | +4.06% | -4.13% | -0.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.34B 2.94B 2.73B 2.51B 4.71B 323B 4.79B 32.63B 12.73B 158B 12.54B 12.27B 547B | 3.54B 3.11B 2.89B 2.66B 4.99B 343B 5.07B 34.56B 13.48B 167B 13.28B 12.99B 580B |
| Net income | 609M 536M 498M 458M 858M 58.98B 874M 5.95B 2.32B 28.77B 2.29B 2.24B 99.8B | 686M 603M 560M 515M 966M 66.4B 984M 6.7B 2.61B 32.38B 2.57B 2.52B 112B |
| Net Debt | -107M -94.11M -87.42M -80.41M -151M -10.36B -153M -1.05B -408M -5.05B -402M -393M -17.53B | -741M -652M -606M -557M -1.04B -71.78B -1.06B -7.24B -2.82B -35.01B -2.78B -2.72B -121B |
| Date | Price | Change |
|---|---|---|
| 26-07-23 | €319.80 | +1.81% |
| 26-07-22 | €314.10 | -0.25% |
| 26-07-21 | €314.90 | +1.81% |
| 26-07-20 | €309.30 | -1.31% |
| 26-07-17 | €313.40 | -0.63% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
- WPS Stock
Select your edition
All financial news and data tailored to specific country editions
